SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " lead " 17,274 found 🔀 AI-powered Shuffle
4 iconic American CEOs are making way for nuts-and-bolts leaders
Warren Buffett, Tim Cook, Bob Iger, and Doug McMillon are making way for nuts-and-bolts leaders, but success will require more than an eye for detail.
Caleb Williams Calls Out NFL, Echoes Bold George Kittle Message
Chicago Bears quarterback Caleb Williams is already a leader of his team, and now he is leading with regards to the entire NFL. The post Caleb Williams Calls Out NFL, Echoes Bold George Kittle Message appeared first on HEAVY.
The 10 highest-rated Georgia Bulldogs in College Football 27
Georgia earns an 87 overall rating in College Football 27 with safety KJ Bolden leading the roster. Gunner Stockton appears not to be in the game
Jeffries Faces Steep Test as Far Left Builds Strength in Congress
The victories of Darializa Avila Chevalier and other anti-establishment candidates are changing the face of House Democrats, posing a challenge for their leader.
Nigel Farage’s anti-WHO campaign moves to US with allies added to board
Relocation of Action on World Health raises questions over why Reform UK leader is involved in a US pressure group
Nigel Farage’s anti-WHO campaign moves to US with allies added to board
Relocation of Action on World Health raises questions over why Reform UK leader is involved in a US pressure group
Apple A20 Pro motherboard leak hints at notable memory and packaging upgrades
A leaked package layout of Apple's A20 Pro hints at several notable upgrades for the iPhone 18 Pro series. The next-gen SoC is said to feature a wider 96-bit memory interface, a redesigned packaging approach for improved thermals, and a larger Neural Processing Unit (NPU).
Days Ahead to Show If Burnham Plays Politics Better Than Starmer
Standing across from Keir Starmer in the Commons chamber this week, opposition leader Kemi Badenoch drew on a particularly violent metaphor for how the Labour Party had ditched him when she conjured up an image of “400 knives stuck in the prime minister’s back.”
Baylor teen health clinics provide free medical care, mental health services
According to the latest U.S. Census data, Texas leads the nation in the number of uninsured residents.
Muslera blunders, sets unwanted Cup record, and socials pounce
In Guadalajara, Mexico, Spain is leading Uruguay 1-0 this Friday (26), in the third round of the group stage of the 2026 FIFA World Cup.La Celeste’s partial defeat, in fact, is securing Cape Verde��...
Will Cannon posts second-round 61, leads Memorial Health Championship presented by LRS
Will Cannon grabs a one-shot lead through 36 holes at the Memorial Health Championship presented by LRS after posting a 10-under 61 on Friday.
Healthcare AI Leaders Are Rapidly Trying To Outmaneuver Skyrocketing Memory And GPU Costs
Compute power has become one of the most crucial components of the healthcare delivery cycle.
Business Honor Roll picnic celebrates community support
The Business Relations Committee at MyMichigan Medical Center Alpena recently welcomed local professionals and industry leaders to a Business Honor Roll Appreciation Picnic hosted by Alpena Agency in their downtown location. Established in 1994, the Business Honor Roll brings together local companies and corporations interested in strengthening health care for our region. Through annual contributions […]
Peters, Bergman lead Michigan delegation in calling on Small Business Administration to approve disaster declaration
WASHINGTON, DC — U.S. Senator Gary Peters (D-MI), Ranking Member of the Homeland Security and Governmental Affairs Committee, led members of the Michigan Congressional Delegation in urging the Small Business Administration (SBA) to support Michigan Governor Gretchen Whitmer’s request for an administrative disaster declaration following the severe thunderstorms, tornadoes, high winds, large hail and torrential […]
Jackson Parish young business leaders class
Town of Jonesboro and Mayor James Harris look to host class for young kids learn the business world
Hightower president leaving after less than three months
Roberto Stewart, who was named president in April, had been tapped to lead the improvement of the firm's technology platform.
DC Wrap: U.S. strikes Iran; Bolton pleads guilty
A look at the day's biggest stories in national politics
DC Wrap: U.S. strikes Iran; Bolton pleads guilty
A look at the day's biggest stories in national politics
The 5-Question Org Chart Audit I Run Before Scaling AI Across a Business
AI success depends less on the technology and more on the organization behind it. These five questions help leaders identify the structural barriers that prevent AI from delivering real business impact.
New for MNSSHP 2026: Captain Jack Sparrow Leads Pirate Entertainment in Adventureland
Captain Jack Sparrow joins MNSSHP 2026 in Adventureland with a new pirate entertainment act. The Rusty Cutlass band has not appeared on any confirmed 2026 lineup yet.
Business Matters - Sit Down with David Jaindl and Rich Lerner
Join host Tony Iannelli for a compelling conversation with David Jaindl, one of the Lehigh Valley’s leading land development professionals, and Rich Lerner of GOLF Channel. Together, they discuss the
Are You Falling Into These 5 AI Traps? Here's How Smart Leaders Avoid Them.
Artificial intelligence is making founders fall into the same leadership traps. Here's how to make sure you avoid them.
The Year 536 AD Was So Bad It May Have Been the Worst Time in Human History to Be Alive
Volcanoes, famine and plague made 536 a leading candidate for history’s worst year.
Essentia again ranks among Minnesota's best for quality care
Minnesota Community Measurement (MNCM) — a statewide resource providing timely, comparable information on healthcare quality, costs and equity — once again ranks Essentia Health as a quality leader in its annual Health Care Quality Report.
Kroenke Sports & Entertainment deemed most valuable sports empire
The Jones family ($17.6B) and Harris Blitzer Sports & Entertainment ($16.91B) followed KS&E in the CNBC rankings.
Nebraska Hispanic Chamber of Commerce holds networking event for Omaha businesses
Watch: Omaha business leaders met at Mexico's consulate to network with the Nebraska Hispanic Chamber of Commerce
Ex-national security adviser John Bolton pleads guilty to illegally retaining classified information
Former Trump administration national security adviser John Bolton pleaded guilty on Friday to illegally retaining classified information, sealing a deal with federal prosecutors that could allow him to avoid a prison term.
Some In Silicon Valley Want To Build A Machine God: Here's What Business Leaders Should Build Instead.
What young people need to become capable, grounded adults is not a faster model release.
Inside the courtroom where Trump’s former adviser-turned-critic John Bolton just pleaded guilty
Amid lingering disparities, Tulsa business leaders explore how to increase diversity
Tulsa business leaders discussed how workplace diversity and inclusion can strengthen economic growth during the Tulsa Regional Chamber's State of Inclusion event.
John Bolton pleads guilty to illegally retaining classified information
His plea deal with federal prosecutors could help him avoid prison time
Take an 8-Minute Gameplay Tour of the Remade Havana in Assassin's Creed Black Flag Resynced
Join Assassin's Creed Black Flag Resynced lead level designer Jean Strachen as she takes you on an eight-minute gameplay tour of Havana. See what it looks like now in the gorgeous new remake that will be released for PC, PS5, and Xbox Series X|S on July 9.
Two Yankees Pitching Prospects ‘Turning Heads’ in Minors This Year
The old saying is you can never have enough pitching, which the New York Yankees have apparently taken to heart. The Yankees have a stockpile of potential starting-pitching arms in the minor leagues, including Elmer Rodriguez, and two “head turning” prospects, Ben Hess and Chase Hampton. The Yankees lead the majors in team ERA (3.30) […] The post Two Yankees Pitching Prospects ‘Turning Heads’ in Minors This Year appeared first on HEAVY.
ECU Health announces 2026 Board Quality Leadership Award winners
ECU Health Board Quality Leadership Award winners were recognized for delivering exceptional experiences and advancing patient outcomes.
David Glew to Lead Cameron School of Business as Interim Dean
The University of North Carolina Wilmington has selected David Glew to serve as interim dean of the Cameron School of Business, effective July 1.
Business Leader Tim Giroux Announces Candidacy for Nevada Joint Union High School District Trustee
GRASS VALLEY, Calif. – June 26, 2026 – Tim Giroux, a business leader and community member rooted in the Auburn/Grass Valley area since 1999, today announced his candidacy for Trustee of the Nevada Joint Union High School District. The election will be held in November 2026. Giroux brings more than 40 years of business ownership […]
Past participants are now the leaders of MIT’s dynaMIT Club
The MIT student club dynaMIT teaches STEM principles to local middle school students for free every summer. They use fun, innovative experiments to inspire the next generation of scientists and engineers.
Ex-Trump adviser John Bolton expected to plead guilty in classified information case
Bolton to plead guilty charges that he unlawfully retained sensitive national security information in agreement that includes $2.25m fine
Earthquake shifts political ground for Venezuelan leader Delcy Rodriguez
Venezuela's strongest earthquake in over a century is the biggest challenge to Delcy Rodriguez's leadership but could also allow the interim president to stamp her authority on a fractured government.
Chairman Guthrie, Health Vice Chair Harshbarger, Congresswoman Miller-Meeks Lead Site Visit to Iowa Hospitals to Highlight Benefits of the Rural Health Transformation Program
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
Braille is literacy: Rice researchers are reshaping the science of reading
As schools across the country increasingly embrace evidence-based approaches to reading instruction through the science of reading, two Rice researchers are leading an effort to ensure students who learn through braille are not left out of the research shaping literacy education.
Sweden and WHO launch new long-term initiative to transform Ukraine’s health system
WHO and the Swedish International Development Cooperation Agency (Sida) have launched a new multi-year cooperation project to support the long-term recovery and transformation of Ukraine’s health system. The new project, “Ukraine’s Health System Transformation Initiative: Strengthening Health Governance, Health Financing and Service Delivery for Long-Term Recovery”, was launched at the Ukraine Recovery Conference 2026 in Gdansk, Poland on 26 June, and will run from June 2026 to 2029. Sweden will contribute approximately US$ 26 million (240 million Swedish krona) to support this project. This contribution forms part of Sweden’s broader support to Ukraine through the Team Europe approach, which brings together the European Union, its Member States, and key partners such as the European Commission’s Directorate-General for Enlargement and Eastern Neighbourhood and Enabel, and WHO as lead health agency, to support Ukraine’s recovery, reform agenda and European integration.“Ukraine’s health recovery cannot be measured only by what is rebuilt, but by whether people can count on the health system when they need it most. The scale of the task is immense, with health reconstruction and modernization needs estimated at US$ 19.4 billion over the next decade. Sweden’s US$ 26 million contribution to Ukraine’s Health System Transformation Initiative is a timely investment in the institutions, financing and services that will support Ukraine’s long-term recovery and European integration. WHO remains a trusted partner of the Government of Ukraine in advancing this process. I am deeply grateful to Sweden for its consistent support and partnership,” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. More than 4 years of war have placed unprecedented pressure on Ukraine’s health system, creating 3 interconnected challenges. The first is responding to the immediate consequences of the war and the urgent health needs of the population. The second is recovering and modernizing health services today. The third is continuing reforms and aligning the health system with European standards in the context of Ukraine’s future accession to the European Union. The war has led to large-scale population displacement, an increasing need for trauma care and rehabilitation, and shortages of health workers. High out-of-pocket payments in Ukraine make access to health services more difficult. Around 46% of total health expenditure is paid directly by individuals, placing a significant financial burden on many households and underscoring the need for reforms in health financing. Older people, persons with disabilities, women, children and veterans continue to face the greatest difficulties in accessing health services. “Ukraine is demonstrating that health system transformation can continue even during war. Ukraine is also continuing to align its health system with European norms and standards. WHO is committed to supporting Ukraine on this journey. We provide technical support, help coordinate partners’ efforts and support the institutional changes needed to strengthen the system. We are grateful to Sweden for its support. Through this partnership, we can help Ukraine build a more resilient, accessible and people-centred health system,” said Dr Jarno Habicht, WHO Representative in Ukraine. About the Health System Transformation InitiativeThe new initiative will support Ukraine through 3 interconnected areas: strengthening governance and coordination of health sector reforms through more inclusive coordination platforms and structured policy dialogue; transforming service delivery by reinforcing a primary health care-centred model that integrates family medicine, nursing and midwifery; and improving financial sustainability by supporting reforms that ensure the long-term viability of the national health system and reduce out-of-pocket payments for households. Overall, these reforms are expected to make the health system more coherent and easier to navigate, improve the quality and continuity of care, and ensure more equitable access to services, particularly for those who need them most. They will also support Ukraine’s progress towards a more modern health system aligned with European standards. “We are convinced that long-term recovery is not possible without strong, high-quality, person-centred health services that are accessible to everyone. Our partnership with WHO is designed to support deep and lasting systemic changes. Investments in human capital especially autonomous midwives, whose role for maternal, newborn and adolescent sexual and reproductive health cannot be understated, stronger governance, digital transformation and the financial sustainability of the health system are investments in Ukraine’s future. We are proud to support this process,” said Malin Perhult, the Head of the Ukraine Unit at Sida. Focus throughout implementation will be given to the most vulnerable population groups, including older people, women and children, and persons with disabilities, who have been affected by the war and face greater health-care needs. The initiative will be implemented in close cooperation with the Ministry of Health of Ukraine, the National Health Service of Ukraine, the Public Health Centre of Ukraine, regional authorities and international partners. This project will help Ukraine move towards a system where everyone can access the health care they need. It will strengthen primary care, make the health finance system more stable and predictable, and reduce the out-of-pocket costs that Ukrainians face when using health services. As a result, the Ukrainian health system will become more aligned with European standards and more sustainable in the long run.
Trump foe John Bolton is set to plead guilty. Here’s why the case didn’t fall apart
As several criminal investigations into President Donald Trump’s foes continue to flail, federal prosecutors are now ushering one of his biggest critics to a conviction.
Elroy Air to Become Publicly Traded Company via Business Combination with Inflection Point-led SPAC
Elroy Air, Inc., a leading U.S.-based technology developer of autonomous heavy-cargo drones for defense, rapid response and commercial logistics, and Columbu...
Massachusetts marijuana legalization repeal question battle heats up
Cannabis industry leaders are urging businesses to take the initiative seriously after many previously dismissed its chances.
Bank of America community roundtable highlights sales tax increase, small business struggles
Business and government leaders also discussed hiring trends and the importance of the Charlotte Douglas International Airport.
Enterprise AI spending grows, OpenAI leads, RBC reveals
RBC's latest CIO survey finds no AI token panic, no SaaSpocalypse, and surging enterprise AI spending, led by OpenAI.
Slotkin says Democratic Party needs 'new leadership': 'Old models are no longer working'
Sen Elissa Slotkin calls for new Democratic Party leadership, saying old models no longer work and the party must simplify its message to win back voters.
County Invites Youth, Camps To Register For ‘Mind Your Business’ July 7 - Town-Crier Newspaper
Palm Beach County’s Mind Your Business Youth Entrepreneurship Forum returns on July 7, offering a full day of hands-on learning and innovation for young people across the county. Now in its seventh year, the forum is designed to inspire the next generation of creators, problem-solvers and emerging business leaders. Open to youth ages 10 to […]
Senate Indian Affairs Committee Advances Mark Cruz’s Nomination to Lead Indian Health Service
U.S. Senator Lisa Murkowski (R-Alaska), Chair of the Senate Committee on Indian Affairs, led a nomination hearing to consider Mr. Mark Cruz, of Oregon, to be Director of the Indian Health Service within the U.S. Department of Health and Human Services and expressed her intent to support his nomination. Representative Tom Cole (R-Okla.), a citizen […]
Healthy Employees Are Good. Healthy Leaders Matter More
Healthy, sharp employees are essential to a strong organization. But sequencing matters. High-performing organizations start with leaders.
Prosperity Council’s Report Challenges Kotek to Signal That Oregon Is Open for Business
The 15-member panel of business and labor leaders proposed four modest tax code changes, replacing the Climate Protection Program, and some less controversial reforms.
NBA fans troll Victor Wembanyama after MVP chants in France
Victor Wembanyama is back in France after leading the San Antonio Spurs to the NBA Finals. While his team failed to win the championship, he still received a lot of love from his countrymen. The 7-foot-4 center entered a club…
It's Xbox's turn (again), as console prices keep going up
Microsoft announced a price hike for the Xbox Series consoles today, the third in little over a year. Effective August 1, the Xbox Series S, which launched in 2020 for $300, will cost $500 in the U.S. The Xbox Series X, which launched in 2020 at $500, will go for $800. This follows a round of PlayStation 5 price increases from Sony this spring, and a slow-motion increase for Nintendo’s Switch 2, which will kick in in the U.S. in September. (Mind you, there were also eight video game industry price hikes in six months of 2025). The chart up top shows the sudden ascent of console prices over the past year, a sudden surge in an already unusual hardware generation. Prices had been flat for years, now “up” is the new “flat.” Game console prices used to go down across the length of a console generation, but not this time around. Microsoft’s explanation for the new price hike today: We hoped another price increase would not be necessary, and we have spent the last several months working with suppliers on options. Unfortunately, console storage and memory prices have increased by more than 2.5x and we expect another doubling by the fall of 2027. The entire consumer electronics industry is struggling with the current components crisis, but the effects are particularly hard on consoles. Unlike phones, computers, speakers, and other consumer devices, consoles are typically not sold at a profit, but instead for less than they cost to make. This is an issue well beyond game consoles. Apple announced price hikes on its computers and tablets today as well. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: Brutal Bungie cuts Bungie laid off “most” of its Destiny development team and some developers who worked on Marathon, the newest game from the struggling Sony-owned studio. A WARN notice issued by Sony to Washington State, where Bungie is based, tallied cuts impacting 292 workers, effective next month. That’s strictly for Bungie/Sony jobs in Washington and wouldn’t account for any elsewhere. The video I clipped below shows the redacted list of Bungie cuts filed to Washington State officials. As you’ll see, I had to scroll for a while… In a note emailed to PlayStation workers and published online, PlayStation game studios chief Hermen Hulst offered the following explanation for these latest cuts at Bungie: This is painful news, especially for talented colleagues whose roles have been eliminated. This decision was made only after extensive discussion and careful consideration, and I want to provide some context on how we arrived here. Over the past several months, together with Bungie leadership, we reviewed the studio’s long-term direction, development priorities, resource needs, and role within our broader portfolio strategy. We explored multiple alternatives before concluding that a reduction was necessary to align the studio’s resources with its current priorities and long-term goals. In 2022, Sony bought Bungie for $3.7 billion. The studio’s marquee game, the multiplayer live service shooter Destiny 2 was losing popularity at the time. Its next game Marathon, released earlier this year, has been well-reviewed but had a slow start. Bungie is renowned for making great shooter games, and Destiny fans have mourned the wind-down of Destiny 2. They’ve also expressed bewilderment over reports that Destiny 3 is not, per Bloomberg, immediately in the cards.
Evaluating the robustness and readiness of large frontier models in health AI applications
Nature Medicine - Adversarial evaluation of leading AI models uncovers gaps between benchmark success and robustness, highlighting limitations in current health AI benchmarks and their ability to...
New district leaders could take over Brooklyn Democratic Party
The current chair said she believes in "moving forward."
Blue state leaders erupt after Supreme Court’s decision ending TPS protections for Haitians, Syrians
Supreme Court rules 6-3 in favor of Trump administration in two key immigration cases on Temporary Protected Status and asylum, drawing opposition from blue state Democrats.
David Clayton-Thomas, Blood, Sweat and Tears singer, dies at 84
David Clayton-Thomas, best known as the lead singer of the Grammy-winning jazz rock group Blood, Sweat & Tears, has died. He was 84.
WATCH: House Democratic leaders hold hearing on fair elections and voting rights
House Minority Leader Hakeem Jeffries and Democratic lawmakers held a hearing Thursday on defending fair elections and voting rights.
FlashPoint: How a Christian political media network became a platform for Indiana’s Lt. Gov.
By Sydney Byerly The Indiana Citizen June 25, 2026 When Indiana Lt. Gov. Micah Beckwith called Islam a “demonic death cult” during an appearance on the Christian political program FlashPoint in May, the remarks drew swift backlash from faith leaders across Indiana. It also highlighted the growing influence of the Christian media network that amplified
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
The Politics Hour: The big winners in MD's primary elections
Leading Democratic nominee for Montgomery County Executive Will Jawando talks about his message to voters, dark money, and data centers. Plus, Tara Jackson wins the Democratic nomination for Prince George's County State's Attorney and WAMU's Alex Koma on D.C. lawmakers greenlighting the budget.
Who is Anuk Karunaratne? Meet the Cardinals’ new President of Business Operations
The St. Louis Cardinals formally promoted Anuk Karunaratne to the role of President of Business Operations on Wednesday as the franchise unveiled changes to its organizational leadership structure.
Trump budget request omits funds for L.A. fire relief, prompting criticism from senators
The omission is the latest strain in a yearlong standoff between California leaders and the Trump administration over federal disaster aid.
2-RBI days from Henry Davis, Brandon Lowe lead the Pirates to a series win against the Mariners
The Pirates continually walked a tightrope. The Seattle Mariners never let them fall. The Pirates beat the Mariners 5-1 on Thursday afternoon at PNC Park...
Chris Evert shares devastating health update
It is the news that no one wanted to hear about Chris Evert. Amid the Netflix press tour and her upcoming ESPN commentary duties at Wimbledon, we learned on Wednesday that she quietly stepped away to deal with a health…
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence
Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.
Romeo Doubs' Exit Could Raise the Stakes for Jordan Love in Green Bay
Jordan Love and the Green Bay Packers are eyeing a bounce-back campaign in 2026. The Packers opened the 2025 season with a strong start, posting a 9-3-1 record through their first 13 games, before a flurry of injuries derailed Green Bay's Super Bowl hopes. Since taking over as Green Bay's starter under center, the Utah State product has shown flashes of a top-five signal-caller, though the team hasn't yet made it past the divisional round under his leadership.
Consumer Discretionary Stocks Drawing Institutional Rotation Into Live Entertainment Leaders
With the Federal Reserve hinting at a pause in rate hikes, stubborn inflation still in the background, and several large companies surprising on earnings, consumer discretionary stocks are back in focus for investors weighing risk and opportunity. This article looks at how that mix of easier policy signals, solid corporate reports, and ongoing geopolitical and supply chain issues could affect larger U.S. consumer-focused companies. It will walk through 3 stocks from a curated screener that...
This Week in Jacksonville: Business Edition - Tim Cost reflects on 14 years leading Jacksonville University
As Jacksonville University prepares to welcome new leadership, outgoing President Tim Cost says his focus remains on the institution’s future rather than his own legacy.
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Grading college football rosters for Year 1 coaches: Pete Golding, Ole Miss earn top marks
Pete Golding and Ole Miss lead the pack as we grade how college football's newest head coaches fared in rebuilding their rosters ahead of the 2026 season
Major blow for MacBook Ultra: Apple said to cancel M6 Pro and M6 Max
The Apple MacBook Ultra will either be released with the older Apple M5 Max, or its launch will be significantly delayed. This is because Apple is said to have halted development of the Apple M6 Pro and M6 Max in order to focus on the M7 series instead, which is expected to offer significantly stronger AI performance.
In second term, is Wu warming to business leaders?
In her second term, Boston Mayor Michelle Wu is developing closer ties with business leaders.
Proposed CDC science office could tighten political control at agency
Under President Trump, political leaders are exerting more control across federal health agencies.
Survey finds Roy Cooper continues to hold double digit lead in N.C. Senate race
A new survey finds former North Carolina governor Roy Cooper leading former Republican National Committee Chair Michael Whatley by double digits in the pivotal Senate race in November.
Rush CEO to step down, take health equity mission to national stage
Dr. Omar Lateef said he is handing off a health system at the top of its game and expects healthcare leaders from around the nation will be clamoring to fill the role.
Alex Freeman Headlines Kids Of Former NFL Players Making Their Names In Other Sports
Team USA's Alex Freeman is leading the charge of breakout athletes across sports with NFL bloodlines.
Windcrest welcomes new restaurants, businesses as city works to close revenue gap left by Rackspace
Windcrest leaders say the city is gaining momentum in its effort to attract new businesses and rebuild sales revenue after Rackspace left behind a more than a $1 million gap in the city’s annual budget.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
Health Union Launches 2027 Innovation Suite, Pairing Community Leadership with AI to Accelerate Patient and HCP Connections
/PRNewswire/ -- Health Union, the pioneer in online health communities operating 125+ condition-specific sites reaching over 50 million patients and 9.5...
CU Director of Sports Medicine Dr. Eric McCarty Provides Capitol Hill Briefing on College Athletics Landscape
The University of Colorado's Director of Sports Medicine Dr. Eric McCarty was among a prestigious panel of physicians and coaches leading a briefing on Capit...
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Ebola response highlights value of African science
With African scientists leading the way in the latest Ebola response, Catherine Kyobutungi makes the case for long-term investment.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Rochester Business Hall of Fame announces Class of 2026
Junior Achievement of Central Upstate New York and the Rochester Business Journal announced that three business leaders will be inducted into the Rochester Business Hall of Fame in 2026, joining 155 others who previously have been honored for their contributions to Rochester.
Before governor's race, Xavier Becerra was depicted in kids novels
In Kitty Felde's young adult novels, the lead character is modeled after a girl she'd mentored in L.A. For the father, she picked a certain ex-L.A. congressman.
New Media Event Jupiter Festival Planned from Art Basel Company
MCH Group, in which the Fox scion is the largest shareholder, is launching an event titled the Jupiter Festival with an eye toward becoming a stop on the thought leader circuit.
Meta's reckoning has arrived
After years of layoffs, restructuring, and hard-charging management tactics, Meta's leaders are acknowledging a collapse in employee trust and morale.
Griffin Jax Leads Rays Past Royals 5-3 as Tampa Bay Snaps Two-Game Skid
The Rays snapped their two-game skid with a 5-3 win over the Royals as Griffin Jax continued to shine in the rotation. Tampa Bay also got key contributions from Jonathan Aranda, Yandy Díaz, and Jonny DeLuca, while Bryan Baker locked down his 20th save of the season.
Women in Science: Dr Jennifer D’Souza - TIB-Blog
The blog series “Women in Science” introduces women from TIB who share insights into their careers and personal experiences in science. Dr Jennifer D’Souza studied Natural Language Processing at the University of Texas at Dallas, USA, and is now an AI/NLP research group lead at TIB. In this interview, she shares what she finds most rewarding about a career in science, the lessons she has learned along the way, and her hopes for the next generation of women scientists.
Report: Trust In Public Health Is Strongest at the Local Level
Federal advice is now viewed with skepticism, opening a door for state and local leadership.
Mamdani's Success in New York Tests Democratic Party's Willingness to Change
NEW YORK (AP) — New York City Mayor Zohran Mamdani stepped into the national spotlight this week as an ascendant political force within the Democratic Party. Democratic leaders aren't so sure that's a good thing. As progressives cheered across the nation, some of the most powerful Democrats in the ...
Closed-door outburst turns into victory for Trump’s Iran negotiations
Senate Republicans flipped to reject Democrats' Iran war powers resolution, handing Trump a key win as U.S.-Iran peace deal talks continue on.
'Need each other': Macron hosts Meloni after Trump rift
One of Europe's most prominent right-wing leaders will arrive on the French Riviera for her first bilateral summit with Macron, fresh from her fallout with Donald Trump
Two ‘super-puff’ planets are as wispy as cotton candy
TOI-791 b and TOI-791 c are about the size of Jupiter, but 28–35 times less dense.
NATO’s Leader Makes His Case to Trump for Preserving the Alliance
Using charts, Secretary General Mark Rutte appeared to defuse the president’s anger by showing that European countries were “equalizing” defense spending with the U.S.
South Korea arrests Shincheonji church leader for meddling in politics, media report
A South Korean court ordered the arrest of Lee Man-hee, the founder of the Shincheonji Church of Jesus, over allegations he orchestrated an illegal scheme for followers to join a political party, news reports said.
Republic Business Credit Promotes Hebert Seghers to Vice President, Marketing Manager
Republic Business Credit promoted Katherine Hebert Seghers to vice president, marketing manager. In this role, Seghers will continue to lead the company’s
Families, business owners push leadership to break silence following Haywood Mall shooting
Eleven days after shots rang out at Haywood Mall in Greenville, families and business owners are growing frustrated by the lack of answers from Simon Corporate and Upstate-based mall management.